[AVDL] YoY Annual Result on 31-Dec-2017 [#FY]

Stock
[AVDL] Avadel Pharmaceuticals plc
Announcement Date
16-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#FY]
Profit Trend
YoY- 262.94%
Quarter Report
AVDL's Result
AVDL's Financial Summary
View:
Show?
Annual Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 22,334 59,215 103,269 172,741 150,246 173,209 14,775 7.12%
PBT -5,082 -38,582 -113,197 91,469 -9,718 78,394 -90,331 -38.07%
Tax -12,110 -5,356 -17,893 24,215 31,558 37,735 -1,407 43.10%
NP 7,028 -33,226 -95,304 67,254 -41,276 40,659 -84,906 -
Tax Rate - - - -26.47% - -48.14% - -
Total Cost 15,306 92,441 198,573 105,487 191,522 132,550 99,681 -26.80%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 31.47 -56.11 -92.29 38.93 -27.47 23.47 -574.66 -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS 0.13 -0.89 -2.55 1.66 -1.00 1.00 -2.34 -
EPS Diluted 0.13 -0.89 -2.55 1.61 -1.00 0.93 -2.34 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.